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The GTPase Rac-1 Controls Cell Fate
in the Thymus by Diverting Thymocytes
from Positive to Negative Selection
et al., 1997; Han et al., 1997), show defects at the pre-
TCR checkpoint (Turner et al., 1997). Vav-1 has pluripo-
tent functional potential (Bustelo, 2000); its capacity to
activate Rac-1 is clear, but Vav-1 also has an SH2 do-
main and can assemble signaling complexes indepen-
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dently of its actions in Rac-1 activation (Kuhne et al.,London, WC2A 3PX
2000). One way to probe how much of Vav-1 biology is2 National Institute for Medical Research
mediated by Rac-1 is to examine the actions of gain-The Ridgeway
of-function mutants of this GTPase in the thymus. InMill Hill
this context, the developmental problems in pre-T cellsLondon, NW7 1AA
caused by loss of Vav-1 can be restored by expressionUnited Kingdom
of an activated mutant of Rac-1 (Gomez et al., 2000).
Moreover, the expression of constitutively active mu-
tants of Rac-1 are able to induce pre-T cells to differenti-Summary
ate into the CD4CD8 DP subset in the absence of the
pre-TCR in Rag1/ mice (Gomez et al., 2000).The positive selection of CD4 or CD8 single-positive
One central question for thymocyte biology is themature peripheral T lymphocytes and the deletion of
identity of the intracellular molecules and signals thatself-reactive cells are crucial for central tolerance in
determine whether a thymocyte is positively selected orthe peripheral immune system. Previously, the guanine
deleted. Negative selection or deletion is controlled by thenucleotide binding protein Rac-1 has been shown to
/ TCR complex together with the combined function ofcontrol pre-T cell development. The present report
a number of different costimulatory molecules present onnow describes the actions of Rac-1 in thymocyte se-
antigen-presenting cells in the thymic cortex and medullalection. The study reveals that this molecule has the
(Kishimoto and Sprent, 1999; Page, 1999; Li and Page,striking and unique ability to efficiently divert cells
2001). Vav-1, which is known to be regulated by costimu-from positive selection into a pathway of negative se-
latory molecules as well as by antigen receptor trig-lection and deletion. The ability of Rac-1 to switch
gering (Nunes et al., 1994; Acuto and Cantrell, 2000;thymocytes from a destiny of positive to negative se-
Michel et al., 2000), is neccessary for both positive andlection identifies this molecule as a critical regulator
negative selection of thymocytes (Fischer et al., 1995;of the developmental processes in T cells that are
Tarakhovsky et al., 1995; Zhang et al., 1995; Turner et al.,essential for immune homeostasis.
1997). Vav-1/ DPs thus ineffectively make SP mature
T lymphocytes and are unable to delete as normal.Introduction
Vav-1 function in pre-T cells is mediated by Rac-1
(Gomez et al., 2000), but it is not known whether theT lymphocyte development in the thymus is a complex
adaptor function of Vav-1 is more important than itsprocess essential for the formation of the mammalian
ability to regulate GTPases in thymocyte selection. Theimmune system. Different developmental stages of T cells
role of Rac-1 in pre-T cells was revealed by analysis ofwithin the thymus can be defined by expression of core-
transgenic mice expressing constitutively active mu-ceptor molecules CD4 and CD8. Immature T cell precur-
tants of Rac-1, L61Rac-1, and L61Y40CRac-1 in mousesors are found within the CD4CD8 double-negative
thymocytes (Gomez et al., 2000). Transgenic mice with
(DN) compartment where  selection occurs. Cells that
active Rac-1 mutants offer a powerful tool with which to
successfully rearrange their T cell receptor (TCR)  locus
probe the contribution of Rac-1 signaling in thymocyte
and express a functional receptor complex known as selection. Moreover, by using Rac-1 mutants with differ-
the pre-T cell receptor (pre-TCR) proliferate rapidly and ent downstream signaling capabilities, it is possible to
differentiate into CD4CD8 double-positive (DP) cells explore the effector mechanisms used by Rac-1 to con-
(Fehling and von Boehmer, 1997; von Boehmer et al., trol T cell function. Thus, L61Rac-1 is an activated mu-
1999). These cells then undergo TCR  chain gene re- tant that can interact with the full spectrum of Rac-1
arrangements, and upon expression of a functional / effectors, whereas L61Y40CRac-1 is an active mutant
TCR complex are subjected to the processes of positive with a point mutation in its effector domain that restricts
and negative selection that generate CD4 or CD8 sin- its signaling function. L61Rac-1 can interact with PAK
gle-positive (SP) thymocytes that exit to the periphery (Manser et al., 1994; Bagrodia and Cerione, 1999), and
(Jameson and Bevan, 1998; Sebzda et al., 1999). activate JNK and p38 MAP (mitogen-activated protein)
Recent studies have revealed that Rho family guanine kinases (Minden et al., 1995). It can also modulate actin
nucleotide binding proteins/GTPases regulate thymocyte dynamics (Nobes and Hall, 1995; Hall, 1998). In contrast,
development (Gallandrini et al., 1997; Henning et al., 1997; L61Y40CRac-1 cannot activate MAP kinases, but retains
Cleverley et al., 1999; Costello et al., 2000). Notably, mice the ability to control the actin cytoskeleton (Lamarche
lacking Vav-1, a guanine nucleotide exchange protein et al., 1996).
(GEF) which selectively activates Rac GTPases (Crespo Rac-1 acts to mediate the actions of Vav-1 in pre-T
cells, but its function as DPs undergo selection has not
been examined. As described, the Rac-1 regulator Vav-13 Correspondence: d.cantrell@icrf.icnet.uk
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is required for both positive and negative selection lower than normal levels of expression of the //CD3
antigen receptor complex (Figure 1D). The thymic and(Turner et al., 1997). Moreover, Vav-1 and Rac-1 activa-
tion is also known to be regulated by costimulatory mol- splenic phenotypes of L61Rac-1 and L61Y40CRac-1
mice were identical in that both are deficient in matureecules such as CD28 (Kaga et al., 1998), which have
been shown to synergize with TCR signals to drive dele- SPs T cells (Figures 1B and 1D).
tion of thymocytes (Kishimoto and Sprent, 1999; Lucas
and Germain, 2000; Li and Page, 2001; McKean et al., DP Thymocytes Expressing Active Rac-1 Upregulate
2001). Accordingly, the object of the present study was TCR, CD5, and CD69
to use transgenic mice expressing L61Rac-1- and The normal maturation of SP thymocytes requires posi-
L61Y40CRac-1-activated mutants of Rac-1 expressed tive selection of cells expressing functional T cell recep-
in the context of defined TCR complexes to explore the tors and the negative selection of cells expressing self-
actions of Rac-1 on thymocyte selection. Herein, we reactive TCRs. One common cause of failed SP produc-
have found that Rac-1 can switch TCR signals that nor- tion is the failure in signaling by the / TCR complex.
mally lead to positive selection into signals that cause The process of positive selection and the transition of
negative selection, thus identifying this GTPase as a thymocytes from DPs to SPs is associated with a series
critical regulator of selection processes, which are es- of well-characterized phenotypic changes triggered by
sential for central tolerance. the TCR, that can be defined using antibodies reactive
with the TCR complex and CD5 and CD69 antigens. If
there is ineffective TCR signaling, then thymocytes failResults
to normally upregulate these activation markers.
Typically, a small percentage of DPs express the CD69Altered Development of SP Thymocytes
and Peripheral T Cells in L61Rac-1 activation marker, and these correspond to cells that
have been positively selected in response to TCR signal-Transgenic Mice
The generation of transgenic mice expressing the active ing (Swat et al., 1993; Yamashita et al., 1993; Hare et
al., 1999). The CD69 staining profile of L61Rac-1 DPsRac-1 mutants L61Rac-1 and L61Y40CRac-1 in the thy-
mus has been described previously (Gomez et al., 2000). looked relatively normal in comparison to nontransgenic
littermate controls, although there was a reproducibleThymi from Rac-1 transgenic mice are grossly normal in
terms of morphology and size. However, more detailed slight increase in the proportion of CD69-positive cells
(Figure 2B, right panels) in the L61Rac-1 DP thymocytes.analysis of the thymus and peripheral lymphoid organs
reveals changes in late thymocyte development in mice DP thymocytes normally express relatively low levels
of the TCR but during positive selection, TCR levels areexpressing the activated Rac-1 transgenes. The data in
Figure 1 examine CD4, CD8, and TCR flow cytometric upregulated (Ohashi et al., 1990; Swat et al., 1992; Dutz
et al., 1995). In normal mice, three main subpopulationsstaining profiles for thymocytes from L61Rac-1 trans-
genic mice and L61Y40CRac-1 transgenic mice. As of thymocytes can be defined by immunofluorescence
analysis with antibodies specific to the CD3 antigen orCD4CD8 DPs differentiate into SPs, they downregu-
late one of the coreceptors and progressively upregulate the / subunits of the TCR. There is a subpopulation
with low levels of TCR expression that corresponds tothe expression of TCR up to the final stage TCRhigh CD4
or CD8 SP (Ohashi et al., 1990; Swat et al., 1992; Dutz the majority of DP thymocytes; there is a subpopulation
with high levels of TCR expression that corresponds toet al., 1995). Strikingly, thymi from mice expressing the
activated Rac-1 transgenes lack the normal comple- SP thymocytes; and there is a population of cells with
intermediate levels of TCR complexes that correspondsment of cells falling into the staining gates for CD4 and
CD8 SP cells but contain CD4CD8 DPs and DNs to cells that have initiated TCR signaling and selection
and are transitional between the DP and SP stage. As(Figure 1A). There is a subtle skewing of the DN to DP
ratio, the basis for which is augmented pre-TCR signal- shown in Figure 1B, L61Rac-1 thymi lack cells with the
high TCR levels expected in normal SP thymocytes.ing (Gomez et al., 2000). Mature SP thymocytes should
express high levels of the TCR. TCR  chain staining However, L61Rac-1 DP thymocytes have a higher per-
centage of cells expressing an intermediate level of TCR/shows that in Rac-1 transgenic thymocytes, there are
very few cells corresponding to TCRhigh SPs, with an CD3 complexes (Figure 2B, left panels). Another marker
which upregulates during positive selection in responseincreased proportion of cells with intermediate levels of
TCR (Figure 1B). In parallel with the CD4/CD8 analysis, to TCR signaling is the CD5 antigen (Azzam et al., 1998).
The data in Figure 2 (middle panels) also show that DPtotal thymus cellularity was determined. The loss of SPs
is accompanied only by a moderate decrease in thymic thymocytes from L61 transgenic mice have a higher
percentage of cells with upregulated expression of CD5.cellularity (data not shown).
The spleens of L61Rac-1 transgenic mice were also Analysis of CD5, CD69, and TCR levels on normal DPs
and cells from the L61Rac-1 thymi shows that Rac-1analyzed for the expression of different lymphocyte pop-
ulations. Spleens were removed, cell suspensions pro- thymocytes undergo the TCR-driven events that initiate
the process of positive selection. This view was rein-duced, and cells stained with antibodies against the
/ TCR and the B cell marker, B220. Flow cytometric forced by more careful consideration of the CD4/CD8
immunofluorescence analysis of Rac-1 thymi. In normalanalysis revealed that transgenic mice expressing either
L61Rac-1 or L61Y40CRac-1 under the control of the thymi, there is a subpopulation of CD4 cells with inter-
mediate/low CD8 expression that expresses high levelsCD2 promoter have severely reduced (10-fold) numbers
of peripheral / T cells (Figure 1C). The few / T cells of CD5 and upregulated TCR/CD3 complexes. These
cells represent an intermediate population of cells thatfound in the spleens of L61Rac transgenic mice have
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Figure 1. Impaired T Cell Development in Active Rac-1 Transgenic Mice
(A) Thymocytes from L61Rac-1, L61Y40CRac-1 mice, and nontransgenic littermate controls (Ntg) were stained with anti-CD4 and anti-CD8 antibodies
and analyzed by flow cytometry. Two-dimensional dot plots are shown.
(B) Thymocytes isolated from L61Rac-1, L61Y40CRac-1 mice, and nontransgenic littermate controls were stained with anti-TCR antibodies and
analyzed by flow cytometry. Histograms show expression of TCR in total thymocytes.
(C) Cell numbers of T cells and B cells in mice spleens. Spleen cells from 6- to 8-week-old L61Rac-1, L61Rac-1 transgenic mice, and nontransgenic
littermate controls were analyzed for total cellularity and stained for B220 and / TCR as described in Experimental Procedures. Total cell numbers
in each population were calculated on the basis of the percentages obtained by flow cytometry and total number counts. Data are means  SD
(Ntg, n  4; L61Rac-1, n  4; L61Y40CRac-1, n  5).
(D) Spleen cells isolated from L61Rac-1, L61Y40CRac-1 mice, and nontransgenic littermate controls were stained with anti-TCR antibodies and
analyzed by flow cytometry. Histograms show expression of TCR in total splenocytes.
have initiated selection in response to antigen receptor triggered by a functioning TCR. Moreover, it has been
shown that positively selected thymocytes die if re-engagement and are midway in the transition from DPs
to SPs (Suzuki et al., 1995; Lucas and Germain, 1996). moved from appropriate stromal cell support and there-
fore do not mature into SPs (Hare et al., 1998, 1999).In L61Rac-1 thymi, CD4 cells corresponding to these
transitional cells could be seen, that is, with intermediate This process of death by neglect can be rescued by
ectopic expression of Bcl-2 allowing maturation of SPslevels of CD8 that did not fall into the mature CD4 SP
or the normal DP gates. These cells express high levels (Hare et al., 1998, 1999). Indeed, thymic developmental
problems caused by loss of a range of survival signalsof CD5 and high levels of CD69 and intermediate levels
of TCR complexes. can be restored by ectopic expression of the antiapo-
ptotic protein Bcl-2 (Gallandrini et al., 1997; Kondo et
al., 1997; Maraskovsky et al., 1997; von Freeden-JeffryBcl-2 Expression Does Not Restore Thymocyte
Development in L61Rac-1 Mice et al., 1997). Accordingly, we crossed the L61Rac-1
transgenic mice with E-Bcl-2 transgenic mice. TheIn L61Rac-1 transgenic mice, the presence of DP cells
that express upregulated levels of / TCRs and CD5 CD4/CD8 staining profiles in Figure 3 and the numerical
analysis (data not shown) showed that expression ofand CD69 suggests that Rac-1 thymocytes initiate the
process of positive selection. The failure to generate Bcl-2 did not restore the differentiation of SP thymo-
cytes in L61Rac-1 transgenic mice. The failure of ectopicnormal CD4 and CD8 SP thymocytes and / peripheral
T cells could thus be due to a late-stage failure of posi- expression of Bcl-2 to restore thymocyte development
in L61Rac-1 mice is evidence that expression of Rac-1tive selection.
The normal maturation of SPs requires survival signals is not inducing cell death by neglect in the thymus.
Immunity
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Figure 2. Altered Phenotype of DP and CD4 SP Thymocytes in L61Rac-1 Transgenic Mice
Thymocytes isolated from L61Rac-1 transgenic mice and nontransgenic littermate controls were stained with anti-CD4, anti-CD8, and either anti-
TCR, -CD5, or -CD69 and analyzed by flow cytometry.
(A) Dot plots show CD4/CD8 staining profiles of total thymocytes.
(B) Histograms show expression of TCR, CD5, and CD69 in CD4CD8 DP (upper panel) and CD4 SP (lower panels) from control and transgenic
mice (gated as shown in the plots: R1 for DPs and R2 for CD4 SP). The shaded histograms show expression in nontransgenic littermate controls
and the open ones show expression in L61Rac-1 transgenic mice.
Positive Selection Is Switched to Negative Selection sion of L61Rac-1 prevented development of CD8 SP
cells in female HY transgenic mice. Moreover, there wasin L61Rac Transgenic Mice
An explanation for the decreased numbers of normal a severe reduction (90%–95%) of overall thymocyte cel-
lularity in the L61Rac-1/HY TCR transgenic mice (FigureSPs in Rac-1 transgenic mice could be that there is an
increase in negative selection. The complex process of 4B). These data reveal massive deletion of DPs in the
L61Rac-1/HY TCR transgenic mice such that only athymocyte selection is difficult to explore in mice with
a polyclonal T cell repertoire, but can be studied in more small residual population of CD4lowCD8low and DN cells
can be found in these animals. Comparison of cell num-detail in thymi that express a TCR complex with known
specificity. Accordingly, to test the hypothesis that bers shows that expression of active Rac-1 is inducing
deletion of female HY TCR thymocytes to levels compa-Rac-1 signaling could dictate the outcome of thymocyte
selection, we expressed active Rac-1 in TCR transgenic rable to negatively selecting male HY TCR (Figure 4B).
All these results indicate that L61Rac-1 causes nega-models. The HY T cell receptor is specific for the male
HY antigen presented by H-2Db. Thymocytes expressing tive selection of the HY TCR in a positively selective
background. To examine further the effects of Rac-1HY-specific TCR are negatively selected in male H-2Db
mice and undergo massive deletion resulting in very few on thymocyte selection, the L61Rac-1 transgenic mice
were bred with F5 TCR transgenic mice. The F5 trans-detectable DP and SP with a strong reduction in overall
thymic cellularity (Figure 4B; Kisielow et al., 1988). Thy- genic TCR recognizes an influenza nuclear protein pep-
tide in the context of H-2Db, and thymocytes are posi-mocytes from female HY TCR transgenic mice are posi-
tively selected on an H-2Db background and develop tively selected to CD8 SP cells in mice with an H-2Db
background (Mamalaki et al., 1993). The results in Figureinto mature CD8 SP cells. The data in Figure 4B show
that thymi from L61Rac-1/HY TCR transgenic male mice 4D show that in thymocytes coexpressing the F5 TCR
transgene and L61Rac-1, there is a strong reduction inare hypocellular (typically less than ten million cells),
are devoid of both DPs and SPs, and comprise almost thymic cellularity as compared to normal F5 mice. Also,
in Rac-1/F5 TCR transgenic mice, numbers of DPs wereentirely DN cells (Figure 4A). That is, expression of
L61Rac-1 does not prevent the negative selection of the strongly reduced and there was an accumulation of
CD4CD8low and CD8CD4low thymocytes (Figure 4C).HY TCR transgene.
Strikingly, the phenotype of L61Rac/HY TCR female In F5 and HY TCR Rac-1 transgenic mice there is a
dramatic loss of DPs, whereas when Rac-1 was ex-double-transgenic mice was markedly different from the
normal phenotype seen in thymi expressing the HY TCR pressed in mice with a polyclonal repertoire, DP num-
bers in the thymus were in the normal range. It shouldtransgene. The data in Figure 4A show that the expres-
Rac-1 Regulates Negative Selection of T Cells
707
background (Figure 5A, compare top right and bottom
right panels). Rather, DPs are found in normal ratios.
Comparison of total number of thymocytes (Figure 5B)
shows that the strong reduction in thymic cellularity in
F5/L61Rac-1 in 2-m/ mice is reversed in a 2-m/
background. Thus, the deletion of F5 TCR DPs caused
by expression of Rac-1 is TCR/ligand driven.
Rac-1 Effector Mechanisms in the Thymus
The levels of expression of L61Rac-1 and L61Y40CRac-1
in transgenic mice are similar (Figure 6A), and these two
Rac-1 mutants cause indistinguishable phenotypes in
the thymus (Figure 1). The difference between these two
mutants is that L61Rac-1 can bind to all Rac-1 effectors,
whereas L61Y40CRac-1 binds to a restricted subset and
cannot bind to effectors with a CRIB domain (Figure
6B). The ability of Rac-1 to bind to proteins with CRIB
domains allows this GTPase to activate the stress-acti-
vated MAP kinases p38 and JNK (Lamarche et al., 1996;
Bishop and Hall, 2000). Activation of the p38 MAP kinase
has been implicated in the initiation of negative selection
Figure 3. Bcl-2 Expression Does Not Restore Thymocyte Develop- (Rincon, 2001), and we therefore examined whether con-
ment in L61Rac-1 Mice stitutive activation of Rac-1 in the thymus could drive
Thymocytes isolated from nontransgenic, L61Rac-1 transgenic, Bcl-2 activation of p38. In this context, the ability of active
transgenic, and L61Rac-1/Bcl-2 double-transgenic mice were Rac-1 to activate p38 has only been shown in trans-
stained with anti-CD4 and anti-CD8 antibodies. Two-dimensional formed cell lines but has not been examined in primary
dot plots for CD4 and CD8 are shown. The result shown is represen-
cells. The activity of p38 can be monitored by Westerntative of 11 double-transgenic mice analyzed.
blot analysis with phospho-specific antibodies. There is
a low basal level of p38 kinase activity in thymocytes
analyzed ex vivo that declines when cells are culturedbe noted that Rac-1 activation did not cause reduction
at 37C (Sen et al., 1996). The data in Figure 6C showin expression of the TCR transgenes (data not shown).
that the basal activity of p38 in Rac-1 transgenics is lowThe F5 and HY TCR complexes have a distinct reactivity
and indistinguishable from the activity seen in controlto self-ligands that enables them to be positively se-
cells. This basal activity declines when cells are main-lected. In mice expressing the F5 and HY TCR trans-
tained at 37C and can be reinduced when cells aregenes, the majority of DPs will be in the process of
activated by calcium/protein kinase C stimuli. Activationresponding to self-ligands, whereas most of the DPs in
of Rac-1 alone is thus not sufficient to induce or maintain
mice with a polyclonal T cell repertoire will have an
p38 activation in thymocytes.
ineffective TCR, which fails to recognize self-ligands.
The only other direct function of Rac-1, and one that
These cells are thus destined to die by neglect. The fact can be induced by L61Rac-1 and L61Y40CRac-1, is
that Rac-1 induces massive deletion in the presence of modulation of actin dynamics (Bishop and Hall, 2000).
TCR transgenes but not in the polyclonal T cell repertoire Phalloidin staining revealed no difference in levels of
would thus be consistent with Rac-1 causing deletion of polymerized actin and no differences in gross morphol-
cells responding to self-ligands that normally positively ogy between normal cells and those expressing active
select; that is, Rac-1 activation diverts positive selection Rac-1 (data not shown). The actin cytoskeleton has an
to negative selection. If this hypothesis is correct, then important role in regulating cell adhesion. We accord-
the ability of Rac-1 to induce DP deletion in the TCR ingly examined the effect of L61Rac-1 in thymocyte ad-
transgenic mice requires the TCR to be triggered by hesion because activation of Rac-1 has been shown to
endogenous positively selecting ligands and is not due regulate cell adhesion in a variety of cell systems (Bishop
to an autonomous effect of Rac-1. To examine this issue, and Hall, 2000). Thymocytes express the integrin 41
we studied the effect of L61Rac-1 in selection of F5 TCR which acts as the main receptor for the extracellular
transgenic thymocytes bred into a 2-m/ background. matrix protein fibronectin in these cells (Salomon et al.,
2-m null mice have a marked reduction in surface ex- 1994). We analyzed the attachment of thymocytes from
pression of class I MHC molecules and a severe reduc- normal, L61Rac-1, or L61Y40CRac-1 mice to plate
tion in CD8 T cell selection due to their failure to present bound mouse fibronectin. The data in Figure 6D show
peptides in the context of MHC class I (Koller et al., that normal thymocytes have low levels of adhesion to
1990; Zijlstra et al., 1990). Hence, if the deleting effects fibronectin, but this can be strikingly enhanced when
of Rac-1 are dependent on TCR triggering by normally cells are activated via protein kinase C with phorbol
positively selecting ligands, then Rac-1 activation would esters. Thymocytes expressing active Rac-1 have higher
not be expected to induce deletion of F5 TCR expressing levels of adhesion to fibronectin than normal thymo-
thymocytes in 2-m null mice. cytes. Rac-1-induced adhesion is seen in thymocytes
The data in Figure 5A show that there was no accumu- expressing L61Rac-1 and L61Y40CRac-1; it is not maxi-
lation of CD4CD8low and CD8CD4low thymocytes when mal, and can be further enhanced when cells are acti-
vated with phorbol esters.L61Rac-1 and the F5 TCR are coexpressed on a 2-m null
Immunity
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Figure 4. Positive Selection Is Shifted to Negative Selection in L61Rac-1 Transgenic Mice
(A) Analysis of CD4 and CD8 populations in female (top panels) or male (bottom panels) HY TCR transgenic and L61Rac-1/HY TCR double-
transgenic mice. Thymocytes were stained with anti-CD4, -CD8, and -HY TCR antibodies and analyzed by flow cytometry. Panels show CD4/
CD8 profiles gated on TCRhigh thymocytes. The analysis shown is representative of 12 experiments.
(B) Total thymocyte cell numbers from 6- to 8-week-old female and male HY TCR transgenic and L61Rac-1/HY TCR double-transgenic mice.
Histogram bars represent means  SD (females: controls, n  9; Rac transgenics, n  12; males: controls, n  6; Rac transgenics, n  12).
(C) Thymocytes from F5 TCR transgenic and L61Rac-1/F5 TCR double-transgenic mice were stained with anti-CD4, -CD8, and-V8 antibodies
and analyzed by flow cytometry. Panels show CD4/CD8 profiles gated on V8high thymocytes. The analysis shown is representative of six
experiments.
(D) Total thymocyte cell numbers from 6- to 8-week-old F5 TCR transgenic and L61Rac-1/F5 TCR double-transgenic mice. Histogram bars
represent means  SD (controls, n  6; Rac transgenics, n  10).
Discussion The first indication that Rac-1 might be causing nega-
tive selection came from observations of thymocytes
expressing active Rac-1 transgenes that made very fewOne question that has consistently intrigued immunolo-
gists is the nature of the intracellular molecules and SP T cells. The inability to make SPs can reflect failed
positive selection as a consequence of failed TCR signalsignals that lead to positive or negative selection. The
present study shows that the GTPase Rac-1 has a strik- transduction. This is typically observed in thymocytes
lacking expression/function of TCR-coupled signalinging effect on the selection of mature / T cells: in two
different TCR transgenic models, expression of active molecules such as tyrosine kinases Lck and ZAP-70
(Negishi et al., 1995; Hashimoto et al., 1996), adaptorRac-1 causes deletion of DP T cells expressing / TCR
complexes that would normally be positively selected. molecules (Yoder et al., 2001), GTPases (Swan et al.,
1995), and mitogen-activated protein (MAP) kinasesImportantly, Rac-1 does not induce deletion of DPs on
a nonselecting background where interactions with cog- (Alberola-Ila et al., 1995; Rincon et al., 1998; Sugawara
et al., 1998). Rac-1 activation did not reduce expressionnate ligands in the thymus do not occur. The ability of
Rac-1 to induce deletion of DP thymocytes therefore of the TCR. Moreover, one way to gauge the efficacy of
TCR function in vivo in DPs is to look at the ability ofrequires TCR triggering by self-ligands and is not an
autonomous effect of Rac-1. The ability of Rac-1 to thymocytes to upregulate cellular levels of the TCR,
CD5, and CD69. The high levels of TCR, CD5, and CD69switch signaling of a defined / TCR complex from
positive selection to deletion or negative selection is levels on Rac-1 DP thymocytes argue against inefficient
TCR function in these cells. In fact, these data argueunique for a GTPase and establishes Rac-1 as a sensor
that interprets TCR signals to determine cell fate in the the converse and are consistent with augmented TCR
responses in DPs.thymus.
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Figure 5. Thymocyte Deletion in L61Rac-1/F5 TCR Transgenic Mice Is Prevented in a 2-m/ Background
(A) Thymocytes from F5 2-m/, F5 2-m//L61Rac-1, F5 2-m/, and F5 2-m//L61Rac-1 mice were stained with anti-CD4 and anti-CD8
antibodies and analyzed by flow cytometry. Panels show CD4/CD8 profiles in total thymocytes. Numbers in the dot plots indicate the percentage
of DP thymocytes (gated as shown in the dot plots). The analysis shown is representative of three experiments.
(B) Thymocyte cell numbers from 6- to 8-week-old F5 2-m/ (n  5), F5 2-m//L61Rac-1 (n  5), F5 2-m/ (n  4), and F5 2-m//L61Rac-1
mice (n  5). Histogram bars represent means  SD.
One other explanation for the failure to generate nor- that determine thymocyte selection are determined by
the strength of the TCR trigger but are also stronglymal numbers of SPs in Rac-1 mice is that Rac-1 is in-
creasing negative selection. This idea was tested by influenced by cell adhesion and by cosignals given by
antigen-presenting cells (APCs) in the thymus. It haslooking at the effects of Rac-1 activation on thymocyte
selection in two defined TCR transgenic models: the HY thus been proposed that cosignaling by hematopoietic
cells in the medulla by molecules like CD28, or by func-and the F5 transgenic TCR systems. The advantage of
using TCR transgenics is that it ensures that all DPs tional analogs, induces negative selection by aug-
menting the effects of TCR engagement (Kishimoto andexpress a TCR with proven capacity to be positively
selected by self-ligands. The results of these experi- Sprent, 1999; Lucas and Germain, 2000; McKean et al.,
2001). The relevance of these observations to the pres-ments were striking, and showed that Rac-1 caused
deletion and loss of DPs expressing TCR complexes ent study is that CD28 engagement with its physiological
ligands has a well-established ability to activate Vav-1/that should have normally been positively selected. The
deletion of DPs caused by Rac-1 activation was not due Rac-1 and can induce the formation of cell/cell contacts
where Rac-1 translocates to the site of cell-cell contactto some autonomous actions of this GTPase in DPs.
Thus, in mice with a polyclonal repertoire, where most (Nunes et al., 1994; Kaga et al., 1998). Rac-1 activation
is thus associated with the costimulatory signals pre-DPs express a TCR that fails to react sufficiently with
self-MHC, Rac-1 did not cause deletion or loss of DPs. viously shown to cause deletion of thymocytes. More-
over, previous work has shown that mice lacking Vav-1,Rac-1 activation is thus not generically inducing cell
death in DP thymocytes but only in thymocytes with a the upstream regulator of Rac-1, have defective nega-
tive selection (Turner et al., 1997). Thus, although theTCR engaging self-peptides. Hence, analysis of L61Rac-
1/F5 TCR/2-m/ mice showed that Rac-1-induced de- present study interprets the actions of gain-of-function
genetic manipulation of Rac-1, the conclusions are rein-letion was only seen when DPs expressed a TCR com-
plex that could interact with cognate ligands. forced by the loss-of-function manipulations of Rac-1 as
happens in Vav-1 null thymocytes, and by biochemicalFor a single T cell expressing a given TCR, the out-
come of positive or negative selection is dependent evidence that Rac-1 is activated by the types of costimu-
latory signals previously implicated to have a key roleon the strength of the signaling response. Insufficient
signaling results in cell death by neglect; signaling in in negative selection.
One question we have considered is what effectorthe optimal range allows positive selection; any signal-
ing that goes above this signaling threshold results in pathway is used by Rac-1 to control thymocyte selec-
tion. Rac-1 can bind to multiple effectors containing anegative selection of thymocytes so that potentially self-
reactive cells are not exported into the periphery (Seb- motif termed the Cdc42/Rac interactive binding (CRIB)
motif (Burbelo et al., 1995). CRIB domain-containing ef-zda et al., 1999; Hogquist, 2001). The signaling events
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Figure 6. Active Rac-1 Does Not Activate p38 but Enhances Thymocyte Adhesion to Fibronectin
(A) Intracellular staining of myc-tagged Rac-1 in thymocytes. Thymocytes from L61Rac-1 transgenic mice (solid gray), L61Y40CRac-1 mice
(black line), or nontransgenic littermate control mice (solid black) were saponin permeabilized and stained with anti-myc antibody 9E10 to
detect transgene expression as described in Experimental Procedures.
(B) L61Y40CRac-1 does not bind PAK-1 in thymocytes. Cell extracts from either nontransgenic () or Rac-1 transgenic thymocytes () were
immunoprecipitated with anti-myc antibody 9E10 (bottom panel) or incubated with GST-PAK-1 fusion protein and pulled down with glutathione-
agarose beads (top panel). Rac proteins associated with the precipitates were analyzed by Western blotting with anti-Rac antibodies.
(C) L61Rac-1 does not activate p38 MAPK in thymocytes. Freshly isolated thymocytes from L61Rac-1 transgenic mice () or nontransgenic
littermate control mice () were kept at 4C for 40 min or incubated at 37C in RPMI medium for 30 min followed by 10 min incubation on
either medium alone or medium containing Pdbu (50 ng/ml) and ionomycin (500 ng/ml). Activation of p38 MAPK was determined by Western
blotting using anti-phospho-p38 antibodies (top panel). After stripping the membrane, total p38 MAPK was determined by Western blotting
using anti-p38 antibodies (bottom panel).
(D) Both L61Rac-1 and L61Y40CRac-1 enhance thymocyte adhesion to fibronectin. Cell adhesion of freshly isolated thymocytes to increasing
concentrations of fibronectin was assayed as described in Experimental Procedures. Specific adhesion is expressed as a percentage of
attached cells for nontransgenic (circles), L61Rac-1 (squares), or L61Y40CRac-1 (triangles) transgenic thymocytes. Solid symbols indicate
adhesion of untreated thymocytes; open symbols indicate adhesion in the presence of Pdbu. Data represent means  SD of triplicates.
fectors include PAK family serine kinases (Bagrodia and ment (Gomez et al., 2000). Finally, Rac-1 effects on thy-
mocyte development can be induced by L61Y40CRac-1,Cerione, 1999), and also allow active Rac-1 to stimulate
two MAP kinases, p38 and JNK (Lamarche et al., 1996). an active Rac-1 effector domain mutant with restricted
signaling capacity that fails to activate MAP kinasesWe first considered that Racs might control negative
selection by activating p38 and JNK, because previous even in cell lines in vitro (Lamarche et al., 1996).
The best idea of how Rac-1 might control selectionstudies have linked these MAP kinases to deletion
mechanisms in the thymus (reviewed extensively by Rin- stems from the use of the L61Y40CRac-1 mutant, be-
cause this is known to selectively regulate filamentouscon, 2001; Rincon et al., 1998; Sugawara et al., 1998).
However, the direct actions of Rac-1 on negative selec- actin reorganization (Lamarche et al., 1996). Actin has
numerous cytoplasmic functions: cortical actin can dy-tion are not explained by direct activation of p38 by
Rac-1. First, we could find no biochemical evidence that namically regulate lamellipodia formation and would be
important in regulating cell adhesion and motility. Weactivation of Rac-1 was sufficient to activate the p38
MAP kinase pathway in the thymus. Second, there was have seen that thymocytes expressing active Rac-1
have increased adhesion to extracellular matrix proteinsno functional evidence that Rac-1 could activate p38
in the thymus: transgenic mice expressing upstream such as fibronectin. Increased integrin-mediated adhe-
sion is a marker for Rac-1 regulation of the lymphocyteactivators of p38 have been made, such as active MKK6
kinase (Diehl et al., 2000), and the phenotype of these cytoskeleton, but is not a sufficient explanation for the
actions of Rac-1 on thymocyte selection. Hence, we seetransgenic mice is nothing like the phenotype of Rac-1
transgenic mice. Activation of p38 in these mice blocks similar increased integrin-mediated adhesion in thymo-
cytes expressing active RhoA (Corre et al., 2001), andthe DN to DP transition, the opposite of the actions of
Rac-1 which promotes this stage of thymocyte develop- this GTPase potentiates positive selection but does not
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1990). E-bcl-2 mice (strain bcl-2-25), expressing human bcl-2 inswitch positive to negative selection in TCR transgenic
the thymus and peripheral T cell compartments, were a gift of Su-models (Corre et al., 2001). The actions of Rac-1 in the
zanne Cory (Strasser et al., 1991). HY TCR, F5 TCR/Rag1/ homozy-thymus are thus mediated by selective effects of Rac-1
gous transgenic mice, and E-bcl-2 heterozygous mice were bred
on actin dynamics that are unique to Rac-1 and cannot to Rac transgenic mice and the F1 progenies were analyzed. Litters
be mediated by other related GTPases such as RhoA. were typed for inheritance of the Rac and Bcl-2 transgenes by
polymerase chain reaction (PCR) of genomic DNA.The ability of Rac-1 to regulate integrin adhesion will
undoubtedly contribute to its actions on thymocyte se-
PCRlection but additional mechanisms must also be required.
Transgene-carrying mice were identified by PCR with transgene-The effect of Rac-1 activation on thymocyte selection
specific primers: L61Rac-1 and L61Y40CRac-1; Vah2 (5	-GTCCCAAcould be explained if Rac-1 activation could promote and
CCCAGCTTTCCCTG-3	) and U47 (5	-CTAAGATCAAGTTTAGTTCC
sustain T cell contact with cells that present self-antigens, CAC-3	) or Vah4 (5	-GGGGACAATGAGTTTTCTGCTG-3	) and G9114
thereby increasing the duration of antigen receptor liga- (5	-GCCACCATGGAGCAGAAGCTGATCTCCG-3	); E-bcl-2, bcl-2-1
(5	-GGAACTGATGAATGGGAGCAGTGG-3	), and bcl-2-2 (5	-GCAGtion. The ability of Rac-1 to drive T cell deletion could thus
ACACTCTATGCCTGTGTGG-3	). Genomic DNA was purified fromreflect that Rac-1 could augment TCR-mediated signal
mouse ear punches and used as a template for 30 cycles of PCRtransduction into the range that causes negative selec-
(57C annealing, 72C elongation, and 95C denaturation).tion. It is, however, noteworthy that there is accumulat-
ing evidence for an important role for Rac-1-induced Flow Cytometric Analysis
actin dynamics in nuclear processes, notably in chroma- Antibodies (Pharmingen) were conjugated to either fluorescein iso-
tin remodeling (Rando et al., 2000). There is also strong thiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), or
biotin. Biotinylated antibodies were revealed using streptavidin-TRI-evidence that cycles of actin polymerization and depo-
COLOR (Caltag). Thymocytes were stained for surface expressionlymerization can regulate gene transcription (Sotiro-
of the following markers using the antibodies given in parentheses:poulos et al., 1999). We suspect that Rac-1 will thus act
CD8 (53-5.8), CD4 (RM4-5), CD5 (53-7.3), CD69 (H1.2F3), CD3
 (145-
to modify T cell responses at multiple levels. Activation 2C11), / TCR (-chain H57-597), B220 (CD45R, RA3-6B2), HY TCR
of Rac-1 might not directly affect TCR signaling but (T3.70), and V11 TCR (RR3.15). Cell preparation, antibody stainings,
might cause a T cell to reinterpret incoming TCR signals and intracellular staining with anti-myc antibody were performed as
previously described (Gomez et al., 2000).and switch its fate. This view is supported by in vitro
analyses of what happens to antigen receptor-mediated
Analysis of p38 MAPK Activationresponses in cells that either express active Rac-1 or
Activation of p38 MAPK in thymocytes after different treatmentslack Rac-1 activity because they are null for Vav-1 ex-
was determined by Western blotting of whole-cell lysates using
pression. Rac-1 can then activate/potentiate stimulation an anti-phospho-p38 polyclonal antibody (New England Biolabs)
of a diverse range of transcription factors by multiple reactive specifically with the dual phosphorylated forms of p38
pathways including AP-1, NFAT (Genot et al., 1996; MAPK (Rausch and Marshall, 1999). Total p38 MAPK was deter-
mined by Western blotting using a polyclonal antibody reacting withTurner et al., 1998), and NFB SRF (our unpublished
both inactive and active forms (New England Biolabs). Preparationdata). Furthermore, loss of Rac-1 activity in Vav-1 null
of cell lysates and Western blotting were described previously (Go-animals is not associated with defective induction of
mez et al., 2000).
proximal antigen receptor signaling events such as LAT
or SLP-76 tyrosine phosphorylation, but does cause de- PAK-1 Binding Assays
fective transcription factor responses, notably defective To assess PAK-1 binding capacity of active Rac proteins, pull-down
NFB activity (Costello et al., 1999). The different tran- experiments were performed on cell extracts with glutathione
S-transferase (GST) fusion and the Rac binding domain (RBD) ofscription factors targeted by Rac-1 in these in vitro mod-
PAK-1 (GST-PAK-1) (Benard et al., 1999). Freshly prepared thymo-els are regulated by diverse signals, which argues
cytes were washed twice in ice-cold phosphate-buffered salineagainst a selective action of Rac-1 on assembly of TCR
(PBS) and subjected to lysis using buffer (20 mM Tris [pH 7.5], 10%
complexes or induction of a single TCR signal transduc- glycerol, 1% NP-40, 150 mM NaCl, 10 mM MgCl2, 1 mM sodium
tion pathway. orthovanadate, aprotinin, leupeptin, chemostatin [1 mg/ml], and 1
In summary, the present study reveals that the GTPase mM PMSF) containing 20 g of GST-PAK-1. The extract was centri-
fuged at 15,000 g for 15 min at 4C. Supernatants were then incu-Rac-1 has the striking ability to divert thymocytes from
bated with glutathione-agarose beads (Sigma Chemicals) for 1 hrthe pathway of positive selection to a fate of negative
at 4C, washed with lysis buffer, and eluted with SDS sample buffer.selection or deletion. Moreover, the actions of Rac-1 on
Bound Rac was analyzed by Western blotting using a monoclonal
actin dynamics emerge as the key that determines thymo- anti-Rac antibody (Upstate Biotechnology). Cell extracts obtained
cyte fate at this crucial stage of development. in parallel without addition of GST fusion protein were immunopre-
cipitated with anti-myc epitope antibody 9E10, as previously de-
scribed (Brennan et al., 1999), and the bound myc-tagged transgenicExperimental Procedures
Rac proteins were analyzed by Western blotting with anti-Rac anti-
bodies as described above.Mice
Mice were bred and maintained under specific pathogen-free condi-
tions in the Imperial Cancer Research Fund Biological Resources Cell Attachment Assays
Flat-bottomed Maxisorp 96-well plates (Nunc) were left uncoatedUnit. Transgenic mice expressing the constitutively active Rac-1
mutants (L61Rac-1 or L61Y40CRac-1) in the thymus and peripheral as controls or precoated with different concentrations of mouse
fibronectin (Chemicon International) in PBS overnight at 4C. WellsT cell compartments under the control of the human CD2 promoter
locus control region were generated as previously described (Go- were washed twice with PBS, and nonspecific binding sites were
blocked with 1% denatured BSA for 1 hr at 37C. Freshly isolatedmez et al., 2000). Transgenic mice expressing HY TCR were kindly
provided by H. von Boehmer (Kisielow et al., 1988). Mice transgenic thymocytes were washed in RPMI and labeled with 2.5M BCECF-AM
(Calbiochem) in the same medium for 30 min at 37C, followed by onefor the / TCR from the F5 cytotoxic T cell clone were generated
as reported (Mamalaki et al., 1992), and crossed onto Rag1/ further wash. Labeled thymocytes were resuspended in either RPMI
or RPMI containing phorbol-12,13 dibutyrate (PdBu; 50 ng/ml), and(Spanopoulou et al., 1994) and 2-m/ backgrounds (Zijlstra et al.,
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added to fibronectin precoated plates (1  106 cells per well in 100 l gression and differentiation of immature thymocytes in vivo. J. Exp.
Med. 191, 321–334.of medium). Plates were centrifuged at 40 g for 1 min and subsequently
incubated for 30 min at 37C. Nonadherent cells were removed by Dutz, J.P., Ong, C.J., Marth, J., and Teh, H.S. (1995). Distinct differentia-
washing three times in warm RPMI medium. Adhesion was quantified tive stages of CD4CD8 thymocyte development defined by the lack
by recording emission at 530 nm and after excitation at 485 nm, using of coreceptor binding in positive selection. J. Immunol. 154, 2588–2599.
Fluoroscan II (Labsystems). Specific adhesion is obtained by sub-
Fehling, H.J., and von Boehmer, H. (1997). Early alpha beta T cell
tracting background adhesion (mean reading for wells uncoated with
development in the thymus of normal and genetically altered mice.
fibronectin) from the reading for each well. This specific adhesion is
Curr. Opin. Immunol. 9, 263–275.
expressed as a percentage of the total emission before the incubation,
Fischer, K.D., Zmuldzinas, A., Gardner, S., Barbacid, M., Bernstein, A.,that is, percentage of total cell input adhering to the well.
and Guidos, C. (1995). Defective T-cell receptor signalling and positive
selection of Vav-deficient CD4 CD8 thymocytes. Nature 374,
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